Nexentis Technologies Inc. Common Stock

Nexentis Technologies, Inc. is a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech. The company employs 7 full-time employees The company went IPO on 2010-05-26. Through its subsidiary MitoCareX Bio Ltd. The firm uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. The company enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.